2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
3
Skin Carcinoma
1
Patient Satisfaction
1
Melanoma
1
Hematologic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
3
delta 24-sterol reductase
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Propofol
2
daratumumab
1
Vascular Access Devices
1
Uterine Artery Embolization
1
Tranexamic Acid
1
Telemedicine
1
Pilot Projects
1
Patient Transfer
1
Parapsychology
1
Music Therapy
1
Midazolam
1
Mastectomy, Segmental
1
Lidocaine
1
Lead
1
Imiquimod
1
Ibuprofen
1
Fentanyl
1
Exercise
1
Drainage
1
Cystectomy
1
Control Groups
1
Colonoscopy
1
Bandages, Hydrocolloid
1
Anesthesia, Local
1
Ambulatory Care
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Satisfaction
×
Aftercare
×
Clear all
NCT03456167
2021-04-21
ERAS-OncoRe
Alberta Health Services, Calgary
Phase NA
Completed
72 enrolled